MANF Therapeutics receives notices of allowance covering MANF use for PD in Europe
MANF Therapeutics announced it has received a notice of allowance from the European Patent Office covering the use of MANF as treatment for various neurodegenerative disorders, including Parkinson’s disease, as well as a notice of allowance from the Japanese Patent Office. January 17, 2019